Using an experimental evolution approach, we recently demonstrated that the mouse-specific pathogen Friend virus (FV) complex adapted to specific major histocompatibility complex (MHC) genotypes, which resulted in fitness tradeoffs when viruses were exposed to hosts possessing novel MHC polymorphisms. Here we report the analysis of patterns of pathogen adaptation and virulence evolution from viruses adapting to one of three hosts that differ across the entire genome (A/WySn, DBA/2J and BALB/c). We found that serial passage of FV complex through these mouse genotypes resulted in significant increases in pathogen fitness (156-fold) and virulence (11-fold). Adaptive responses by post-passage viruses also resulted in host-genotype-specific patterns of adaptation. To evaluate the relative importance of MHC versus non-MHC polymorphisms as factors influencing pathogen adaptation and virulence, we compared the magnitude of fitness tradeoffs incurred by post-passage viruses when infecting hosts possessing either novel MHC polymorphisms alone or hosts possessing novel MHC and non-MHC polymorphisms. MHC polymorphisms alone accounted for 71% and 83% of the total observed reductions in viral fitness and virulence in unfamiliar host genotypes, respectively. Strikingly, these data suggest that genetic polymorphisms within the MHC, a gene region representing only B0.1% of the genome, are major host factors influencing pathogen adaptation and virulence evolution.
INTRODUCTION
The major histocompatibility complex (MHC) is one of the most gene-dense regions in the vertebrate genome. In humans for example, the MHC locus is roughly 3600 kb in length and contains B224 genes, 40% of which have known immunological functions. 1 Thus, a disproportionate number of genes important for immunity are harbored within a chromosomal region that is B0.1% of the genome. In addition, in humans, susceptibility to almost all known infectious and autoimmune diseases have been linked to polymorphisms within the MHC. 2 Importantly, one of the mechanisms maintaining these demonstrably costly alleles may be the promotion of pathogen fitness tradeoffs that arise as a consequence of pathogen adaptation to specific host genotypes. 3 Classical MHC genes are the most polymorphic loci known in vertebrates, 2 and coevolution with pathogenic microorganisms is thought to be a primary force of selection promoting this diversity. [4] [5] [6] [7] [8] These genes encode cell-surface proteins whose function is central to the cell-mediated arm of the vertebrateadaptive immune response. Specifically, MHC proteins bind and present extracellular and intracellular peptide antigens to circulating T lymphocytes (T cells), whereupon recognition of an antigen bound to an MHC molecule as 'foreign' elicits a T cellmediated immune response. Thus, MHC-mediated antigen presentation has a pivotal role in immune surveillance of host tissues for the presence of infectious agents. 9 The importance of this mechanism of immune surveillance is evidenced by the numerous ways pathogens have evolved to evade MHC-mediated antigen presentation. 10 Moreover, the multiple examples of viruses evolving mutations in MHC-presented peptides during a single infection highlights the speed and specificity by which pathogen adaptation seems to respond to these host factors. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] The evidence presented here suggests that genes within the MHC region (and specifically the polymorphic antigen-presenting MHC genes) are likely to have a strong influence on patterns of pathogen adaptation and virulence evolution. Infectious diseases pose a significant threat to both humans and animals, 21, 22 and understanding the ecological/evolutionary forces that influence infectious disease dynamics in nature is currently an intense focus of research. [23] [24] [25] It has been argued that reduced genetic diversity may increase the burden of infectious disease on host species by facilitating the evolution of more virulent pathogens. 25 It has also been suggested that artificially maximizing genetic variation among individuals at MHC genes (for example, in captive breeding programs) may be a useful strategy for limiting these health consequences; 26 however, this idea has been controversial. 27, 28 Given the importance of MHC-mediated antigen presentation stated above, these arguments imply that adaptive responses by pathogens will be disproportionately affected by MHC variability among individuals, which could be an important factor limiting virulence evolution.
In a previous experiment, we serially passaged Friend virus (FV) complex, 29 a mouse-specific retroviral pathogen, through three MHC-congenic genotypes of BALB/c mice that differed (that is, harbored genetic polymorphisms) only at their MHC region and observed MHC-specific patterns of FV complex adaptation and virulence. 3 This was one of the first data sets obtained from a vertebrate host-pathogen system to directly support antagonistic coevolution as a mechanism capable of explaining the high levels of MHC variability observed in a variety of species. This study also highlighted serial passage as a useful experimental evolutionary approach for addressing fundamental questions regarding the nature of host-pathogen coevolutionary dynamics. Here, in an effort to obtain a quantifiable estimate of the relative importance of MHC and non-MHC polymorphisms as host factors influencing pathogen adaptation and virulence evolution, we serially passaged FV complex through two additional mouse strains (A/WySn and DBA/2J). These genotypes were chosen because they possess novel MHC and non-MHC polymorphisms relative to each other (as well as the three BALB/c MHC-congenic genotypes mentioned above). With these passages we generated viral lineages, which in conjunction with our previously created MHC-adapted lineages represented a set of virus genotypes that had adaptively responded to host genotypes representing varying degrees of genetic dissimilarity: MHC differences only (viruses derived from BALB/c MHC-congenics), and MHC and non-MHC differences (viruses derived from BALB/c, A/WySn and DBA/2J genotypes). By comparing the magnitude of fitness and virulence tradeoffs incurred by adapted viruses exposed to hosts possessing novel (that is, different from their host-genotype-of-passage) MHC polymorphisms alone versus hosts possessing novel MHC and non-MHC polymorphisms, we were able to provide one of the first comparisons of the relative importance of MHC versus non-MHC polymorphisms as factors influencing pathogen adaptation and virulence evolution.
To test the prediction that serial passage of FV complex through the A/WySn and DBA/2J host genotypes resulted in viral fitness and virulence increases, independent cohorts of animals from both genotypes (n ¼ 7-12 per host genotype) were infected with unpassaged virus or their respective post-passage virus genotype for a total of 46 experimental infections. To test the prediction that host-genotype Â virus-genotype interaction effects emerged after serial passage, and to compare the relative importance of MHC versus non-MHC polymorphisms in influencing pathogen fitness tradeoffs, cohorts of all five genotypes (the three BALB/c MHC-congenics, A/WySn and DBA/2J) were infected with virus genotypes derived by serial passage through an unfamiliar host strain for an additional 179 experimental infections. Thus, there are 225 total experimental infections unique to this study that were analyzed independently or in combination with 212 experimental infections from our previous BALB/c experiment.
RESULTS
To determine whether serial passage of FV complex through the A/WySn and DBA/2J genotypes results in pathogen adaptation and virulence evolution, cohorts of animals from each of the genotypes were infected with either unpassaged virus or their respective post-passage virus genotype, and viral fitness and virulence estimates were compared. We observed significantly increased viral fitness in both the A/WySn and DBA/2J postpassage virus genotypes compared with unpassaged virus (one-way analysis of variance; ANOVA (passage effect) : proviral load, F (1, 42) ¼ 73.15, Po0.0001; infectious particle counts, F (1, 44) ¼ 100.76, Po0.0001; Figure 1 and Supplementary Table 1 ). In addition, when comparing disease virulence, we found that infection with post-passage viral genotypes was associated with a significantly more virulent disease outcome (ANOVA (passage effect) , F (1, 45) ¼ 159.81, P ¼ o0.0001; Figure 2a ; Supplementary Table 2) . We also observed significant positive correlations between our two measures of viral reproductive output (proviral loads and infectious particle counts) and spleen weight for all animals infected for this study ( Figure 2b ). Thus, consistent with previous results from our BALB/c experiment, serial passage of FV complex through both the A/WySn and DBA/2J genotypes resulted in significant increases in viral reproductive output per unit time as well as dramatically more severe disease. When averaged across all three serial passage experiments, viral fitness and virulence increased 156-and 11-fold, respectively.
Genotype-specific pathogen adaptation is predicted to result in strong host-genotype Â virus-genotype interaction effects as a consequence of viral specialization on different host genotypes. Thus, after ten rounds of serial passage through different host genotypes we expected to observe a large proportion of the Generalized linear model (GLM) analyses (that is, three individual GLM models) including either host genotype, virus genotype or the host-genotype by virusgenotype (H Â V) interaction effect were used to estimate the percentage of overall variation in viral fitness and virulence explained by these independent variables. Thus, the above table summarizes pooled results from nine independent GLM analyses (that is, three models for each effect used to analyze data sets from our three dependent variables (proviral load, infectious particle counts and splenomegaly)). 'NA' refers to the fact that there is only one virus genotype (that is, the unpassaged virus stock). Therefore, there is no effect of virus genotype or a H Â V interaction effect during infection with unpassaged virus. The percentages reported for viral fitness represent the average between proviral load and infectious particle estimates. See Materials and methods for a description on how percent variation estimates were calculated. One caveat to the variance estimates summarized above is that differences in the numbers of degrees of freedom between models can influence the accuracy with which each model estimates the relative contribution of each effect on overall variation. We would like to acknowledge that the degrees of freedom available for each of our model effects are different (host genotype effect
Therefore, compared with the interaction effect, models estimating the contribution of host genotype and virus genotype are likely to reflect less accurate estimates of the true contribution of each of these variables. Results of independent GLM analyses are provided in Supplementary Tables 6-9 .
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overall variation in viral fitness and disease virulence to be explained by host-genotype Â virus-genotype interaction effects.
To obtain an estimate of the percentage of overall variation in a data set explained by a given factor, we utilized a generalized linear model (GLM) approach (see Materials and methods for details), whereby the amount of variation in a data set explained by a given factor (effect sum of squares) is divided by the total variation (total sum of squares). Consistent with our prediction, we found that the host-genotype Â virus-genotype interaction effect explained the majority (51%) of the variation in viral fitness (averaged between proviral load and infectious particle estimate), compared with the main effects of host genotype (9%) and virus genotype (11%) among hosts infected with post-passage viruses ( Table 1 ). The interaction effect also accounted for 59% of the overall variation in virulence, whereas host genotype explained 32% and virus genotype explained 11%. In comparison, during infection with unpassaged virus, the main effect of host genotype explained B55% and 82% of the variability in viral fitness and virulence, respectively, ( Table 1 ). This decrease in the percent of variation in viral fitness and virulence explained by the main effect of host genotype during infection with post-passage viruses further supports our prediction by showing that the relative contribution of the main effect of host genotype in determining viral fitness and disease severity becomes less important as viruses diversify during serial passage and become specialized on different host genotypes.
As mentioned above, specialization is a predicted consequence of host-genotype-specific pathogen adaptation. Thus, adaptive responses that enhance a pathogen's fitness in one host genotype are predicted to be costly when the same pathogen is exposed to an unfamiliar host genotype. To explicitly test this prediction we compared the fitness and virulence of post-passage viruses exposed to familiar (that is, their host genotype-of-passage) versus unfamiliar host genotypes (host genotypes possessing novel MHC as well as non-MHC polymorphisms). These comparisons were made by utilizing a GLM containing the main effects of host genotype, virus genotype and host familiarity (see statistics section in Materials and methods for rationale). Results from an analysis of data pooled across the BALB/c, A/WySn and DBA/2J comparisons revealed that viral fitness (ANOVA (host familiarity effect) : proviral load À F (1,227) ¼ 57.75, Po0.0001; infectious particles À F (1,217) ¼ 55.42, Po0.0001) and virulence (ANOVA (host familiarity effect) : splenomegaly À F (1,237) ¼ 25.56, Po0.0001) estimates were always higher when post-passage viruses were exposed to familiar versus unfamiliar host genotypes (Figure 3 ). These effects are conserved when experiments are analyzed independently as well (Supplementary Table 3 ). Importantly, these data provide evidence that serial passage through distinct host genotypes results in patterns of genotype-specific pathogen adaptation that result in viral fitness and virulence tradeoffs when an adapted virus is exposed to an unfamiliar host genotype possessing novel MHC as well as non-MHC polymorphisms.
In an effort to obtain a quantitative estimate of the relative importance of MHC versus non-MHC polymorphisms as primary host factors influencing pathogen adaptation, we compared the relative magnitude of fitness and virulence tradeoffs incurred by post-passage viruses exposed with host genotypes possessing novel MHC polymorphisms alone versus novel MHC and non-MHC polymorphisms (that is, novel compared with a post-passage viruses' host genotype-of-passage). On average, exposure to hosts possessing both novel MHC and non-MHC polymorphisms produced the greatest fitness and virulence tradeoffs in adapted viruses compared with exposure to hosts possessing novel MHC polymorphisms alone (Figure 4a, Supplementary Table 4 ). However, this was only significant for proviral load (ANOVA (familiarity effect) , F 1,243 ¼ 6.30, P ¼ 0.01). When we compare the relative proportion of the total observed fitness and virulence tradeoffs associated with exposure of viruses with unfamiliar hosts possessing novel MHC polymorphisms versus hosts possessing novel MHC and non-MHC polymorphisms, we found that MHC unfamiliarity alone explained 64% of the total reduction in proviral load, 77% of the total reduction in infectious particles and 83% of the total reduction in virulence (Figure 4b ). Thus, in our host-pathogen system, polymorphisms restricted to the MHC region have a major role in determining the magnitude of the fitness tradeoffs suffered by viruses infecting unfamiliar host genotypes, which also strongly influences virulence. 'Familiar' refers to the host genotype through which a virus was serially passaged, and 'unfamiliar' refers to a host genotype possessing novel MHC and non-MHC polymorphisms. Viral fitness and virulence estimates are consistently higher (six out of six comparisons) when an adapted pathogen infects a familiar versus unfamiliar host genotype. These data indicate that adaptive responses by a virus to polymorphisms unique to its host genotype-of-passage are costly to viral fitness when the same virus is exposed to an unfamiliar host genotype (that is, viral adaptation is host-genotype-specific). For graphical representation, the data depicted above represents residual variation extracted from a GLM, incorporating the main effects of host genotype and virus genotype. See Supplementary Table 3 3 'Unfamiliar' data sets for each of the three experiments shown above are derived from the following virus-host comparisons: A/WySn-passaged virus was tested in all three BALB/c MHC-congenic genotypes as well as the DBA/2J strain; BALB/cpassaged virus was tested in A/WySn and DBA/2J mice; DBA/2J-passaged virus was tested in all three BALB/c MHC-congenics.
DISCUSSION
Many of the genes within the MHC region have a major role in various aspects of host immunity. Therefore, genes within this region may be particularly important host factors mediating pathogen adaptation. This is the first study to attempt to provide direct experimental support for this hypothesis. In our experiments, a surprising 71% of the overall reduction in pathogen fitness and 83% of the overall reduction in disease virulence observed when an adapted pathogen is exposed to a novel host genotype could be ascribed to novel MHC polymorphisms alone (Figure 4) . Surprisingly, despite only representing B0.1% of the genome, MHC polymorphisms accounted for the majority of variance in viral fitness and virulence observed among host genotypes, even when compared with the combined effect of polymorphisms in the rest (99.9%) of the genome. To our knowledge, this is the first experimental attempt to estimate the relative influence of MHC versus non-MHC polymorphisms on pathogen-adaptive responses and virulence evolution.
Emerging infectious diseases are major threats to both animal and human health, 22 therefore understanding what mechanisms limit the spread and severity of disease is of paramount importance for our ability to combat these infectious agents.
Here, we have demonstrated that serial passage of FV complex through a series of identical host genotypes results in dramatic increases in both pathogen fitness and virulence, and that adapted viruses suffer fitness tradeoffs when exposed to unfamiliar hosts possessing both novel MHC and non-MHC polymorphisms. These patterns are consistent with the hypothesis that reduced diversity among hosts facilitates the evolution of more virulent pathogens, 25 and that host-genotypespecific pathogen adaptation leads to strong hostgenotype Â pathogen-genotype interaction effects (that is, fitness tradeoffs due to host specialization), which have been shown previously to be an important factor underlying observed virulence phenotypes.
3,30-32 Thus, results from our experiments suggest that genetic variation in host populations is likely to be a strong impediment to rapidly evolving pathogens. Serial passage experiments through identical versus alternating host genotypes would be a powerful direct test of this hypothesis.
Previous work using a Mus-malaria model found that host and pathogen main effects rather than interaction effects explained a Figure 4 . MHC polymorphisms alone account for a majority of observed pathogen fitness and virulence tradeoffs. The above figure depicts the cumulative fitness tradeoffs suffered by adapted viruses under one of two treatments; exposure to an unfamiliar (that is, non-host-ofpassage) host genotype possessing novel MHC polymorphisms only, or exposure to an unfamiliar host genotype possessing novel MHC polymorphisms and non-MHC polymorphisms. This allows us to estimate the relative additive effect of non-MHC gene polymorphisms on the magnitude of fitness tradeoffs in adapted viruses infecting unfamiliar hosts. Although exposure to hosts with novel MHC and non-MHC polymorphisms produce the greatest reductions in fitness and virulence of adapted pathogens (a), exposure to hosts possessing novel MHC polymorphisms alone can explain a majority of the observed fitness and virulence tradeoffs (b). For graphical representation, the data depicted above represents residual variation extracted from a GLM, incorporating the main effects of host genotype and virus genotype. See Supplementary Table 4 for summary statistics. Means for each pairwise comparison are connected by lines with error bars representing ± s.d. (**Po0.01, ***Po0.005). The 'familiar' data set represents pooled data from cohorts of animals from all five experimental host genotypes infected with their respective post-passage virus stock. The 'unfamiliar MHC' data set represents pooled data from cohorts of MHC-congenic BALB/c animals infected with a virus stock derived by serial passage through a different BALB/c MHC-congenic genotype. The unfamiliar MHC and non-MHC data set represents pooled data from cohorts of animals infected with a virus derived by serial passage through a host possessing a different MHC region as well as a different background.
Viral adaptation to MHC vs non-MHC polymorphisms JL Kubinak et al
majority of the observed variance in disease severity (although significant interaction effects were observed). 31 Data from animals infected with unpassaged FV complex are consistent with these results as host genotype explained B56% and 82% of the variability in viral fitness and virulence, respectively. In contrast, host genotype only explained 9% and 32% of the variability in viral fitness and virulence associated with post-passage viruses, respectively (Table 1) . Importantly, results from animals infected with post-passage FV genotypes also demonstrate that pathogen adaptation during serial passage produces highly significant hostgenotype Â virus-genotype interaction effects that explain B51% and 59% of the variation in viral fitness and virulence, respectively, (Table 1) . Thus, our data imply that the main effect of host genotype becomes less significant over time as pathogen populations diversify due to host-genotype-specific adaptation. Interestingly, these data are consistent with a hypothesis whereby intrinsic (that is, genetically encoded) resistance variability among host individuals constrains virulence evolution by causing pathogen specialization in each successive host genotype, which is accompanied by virulence tradeoffs (Figure 3) .
We would also like to draw attention to the fact that large-scale serial passage experiments may currently be occurring in commercial livestock facilities, which often house highly related animals in close proximity to one another. This almost certainly contributes to the observed emergence of novel and/or more virulent pathogens from such settings; 33 ,34 yet few studies have looked at this explicitly. Compounding this problem is the fact that one current method for limiting infectious agents in such environments is the prophylactic use of antimicrobials, which has now been implicated in the evolution of antimicrobial resistance in multiple pathogenic species. 35 Even more alarming is evidence suggesting that resistance genes emerging on the farm are being passed along to human pathogens, or previously innocuous members of the human commensal microbiota. 36 Thus, it is important that we begin to identify alternative strategies to control rapidly evolving pathogens. Introducing genetic variation among hosts (particularly MHC variation) may be one such strategy that warrants further research.
With regards to the primacy of MHC as a target of pathogen adaptation several things should be considered. First, viral adaptive responses seem to be particularly focused on circumventing various aspects of the antigen presentation pathway, 10 which may be the explanation for why MHC differences between hosts produced such large effects in our experiments. Second, we were limited in our availability of host genotypes, as many inbred mouse strains are completely resistant to FV complex infection. Thus, choosing permissive mouse strains may have biased our results. However, the permissiveness of inbred mouse strains to FV complex is known to be due to the presence of susceptibility alleles at loci linked to the MHC region as well as outside the MHC. 37 Thus, we may have over-or underestimated the importance of MHC polymorphisms in our system. Third, we used inbred strains of mice that posses a limited proportion of the global Mus genetic diversity; it has been estimated that as few as 10 genomic haplotypes could explain the source genetic material for the classical inbred strains. 38 However, many mouse populations are founded by fewer than five individuals (10 genomic haplotypes), 39 so the diversity among our host strains likely reflect conditions often found in nature. Finally, it is important to acknowledge that while our data imply that polymorphic MHC antigen-presenting genes are having the dominant role in our system, there are many other genes within the MHC region that may explain a proportion of the observed effects. Regardless of these caveats, the results described here are striking, given the fact that the MHC region only comprises B0.1% of the vertebrate genome.
Designing future experiments to more explicitly measure the relative contribution of MHC versus non-MHC polymorphisms as factors influencing pathogen adaptation and virulence evolution will be difficult, but is of profound importance. This study is meant to offer a starting point for future studies by providing a direct experimental comparison between tractable levels of genetic diversity. Future work using a broad array of pathogens and gradients of genetic variation will be necessary to address the generality of our results. More broadly, it is our belief that refinement of this model, in conjunction with the myriad of reagents available for the study of mouse genetics and immune system function, will provide a powerful system for elucidating the significance of genetic variation among individuals in determining the evolutionary outcomes of host-microbe interactions.
MATERIALS AND METHODS

Host genotypes
Five genotypes of mice (abbreviated names: BALB/c-H2
d , BALB/c-H2
were purchased from Jackson Laboratories (Bar Harbor, ME, USA) and bred under specific pathogenfree conditions at the University of Utah. All animal use complied with federal regulations and the guidelines set forth by the University of Utah's Institutional Animal Care and Use Committee (08-10017). To simplify discussion, abbreviated strain names listed above are used throughout the manuscript. For additional information regarding these strains, full strain identification numbers and their respective Jackson Laboratories catalog numbers are provided in Supplementary Table 5 . 'H2' refers to the mouse MHC region, and superscript characters refer to unique MHC haplotypes. Ideally, we would have employed a full factorial experimental design (whereby MHC region was constant and the rest of the genome varied, and where MHC was variable but the background was held constant (as in our BALB/c MHC-congenics listed above)). However, this was not possible for two reasons. First, we chose these strains because they were permissive to FV infection (see Discussion). Second, there are no MHC-congenic strains available on the DBA/2J d background, and the MHC-congenic lines available to compare with the A/WySn-H2 s strain are completely resistant to infection. Thus, given our host-pathogen system, we were limited to comparisons among strains that differed at the MHC only (BALB/c MHCcongenics) against strains that differed at MHC and non-MHC genes (BALB/ c versus DBA/2J versus A/WySn). These comparisons still provided us with the ability to contrast the relative importance of MHC polymorphisms versus polymorphisms outside the MHC region in influencing patterns of pathogen fitness and virulence. Finally, previous work has revealed that genetic variation among mouse strains can be high due to hybridization across different Mus musculus subspecies (that is, M.m. domesticus, M.m. musculus, and M.m. castaneus) during their derivation. 40 Moreover, although genetic variation among inbred strains has been shown to be limited compared with global wild Mus diversity, 38 it is probably in line with diversity found in small mouse populations, which is the host diversity level experienced by most mouse pathogens. Thus, the degree of genetic variation among the mouse strains used for these experiments probably approximates the amount of diversity typical among individuals in a wild local Mus population.
Pathogen stocks and serial passage FV 'complex' refers to the presence of a pair of related murine retroviruses that operate synergistically to produce the disease associated with FV complex infection. These viruses are the replication-competent Friend murine leukemia virus and the defective spleen focus-forming virus. An NIH3T3 cell line (3-6a) containing biological clones of the FV complex was kindly provided by Dr Sandra Ruscetti (National Institutes of Allergic and Infectious Disease). This cell line contains the integrated genomes of both retroviruses and was used to create a pool of unpassaged virus stock. This unpassaged stock represents the ancestor of all virus stocks derived in the serial passage experiments described here. Consequently, this stock was used to infect groups of animals from each of the host genotypes in order to obtain baseline fitness and virulence estimates during the test phase of this experiment. Also, because Friend murine leukemia virus facilitates spleen focus-forming virus replication, we restricted our analyses to measures of Friend murine leukemia virus fitness. Serial passage consisted of transferring virus between individuals of a given genotype via intraperitoneal injection of virus-laden spleen supernatants. Spleens were removed from sacrificed animals and mechanically homogenized in an equivalent weight to volume ratio of 1 Â phosphate-buffered saline (0.1 g per 100 ml). Spleens were Viral adaptation to MHC vs non-MHC polymorphisms JL Kubinak et al diluted in this manner as an approximate means of standardizing the infectious dose animals received between passage rounds. During the final test phase of these experiments, animals were infected with ca. 1000 focusforming units (that is, infectious virus particles). Spleen homogenates were spun for 5 min at 10 000 r.p.m. to fractionate homogenized tissue and supernatant. Supernatants were then immediately frozen at À 80 1C until use. Two hundred microlitres of thawed spleen supernatant was used to initiate subsequent rounds of infection, with supernatant aliquots only being thawed once. The duration of infection was 12 days with some passage rounds being terminated earlier if animals were deemed too sick to survive (all infections lasted 10-12 days). Two animals were infected each passage round and their supernatants were pooled. This was done to increase the probability of successfully passaging virus as well as to increase volumes of passage stock. Virus was serially passaged for a total of 10 rounds. During passage round 10, we infected 8-10 animals with round 9 stocks in order to create a sufficiently large pool of post-passage stock virus to conduct all necessary cross-infection studies. Post-passage BALB/c virus genotypes were generated in a previous experiment. 3 Supplementary Figure 1 provides a schematic overview of the experimental design.
Virulence estimates
Erythroblasts are the primary host cell targets of FV complex. The spleen focus-forming virus expresses a fusion envelope protein (gp55) on the surface of infected cells, which constitutively activates the host erythropoietin receptor causing uncontrolled cellular proliferation. 41 These cells migrate from the bone marrow to the spleen and secondarily the liver where terminal differentiation into mature erythrocytes occurs, thus producing an acute disease characterized by gross enlargement of these organs. 42 Thus, for our experiments, we report spleen weight as our estimate of disease virulence.
Pathogen fitness estimates
Two methods were used to obtain viral fitness estimates. Quantitative PCR was used to measure the number of integrated retroviral genomes (that is, provirus) and a tissue culture-based assay was used to measure the number of infectious virus particles in infected animal spleens. Both of these assays have been described in detail elsewhere. 3 Validation of our strategy for normalizing proviral load estimates across qPCR reactions is provided in Supplementary Figure 2 .
Statistical analyses
Statistical analyses were carried out using JMP Start Statistics Pro 9.0 (SAS, Cary, NC, USA). Where appropriate, data were log transformed to meet assumptions of parametric statistical tests. All statistical pairwise comparisons were performed using the ANOVA. To facilitate discussion within the results section, general effects observed across the A/WySn and DBA/2J experiments are reported as the results of one-way ANOVAs based on pooled data across the two experiments. Results of statistical tests for each independent experiment are provided in Supplementary Tables and  are appropriately referenced. To calculate the percentage of variation in a given data set explained by different effects (that is, host genotype main effect, virus genotype main effect and the host-genotype Â virus-genotype interaction effect), we used a GLM employing standard least squares regression analysis. Standard least squares regression analysis provides an estimate of total variation in a data set (the total sum of squares) as well as the amount of that variation explained by a given model effect (model sum of squares). Thus, for each of our three model effects, we performed the following calculation: (model sum of squaresÄtotal sum of squares ¼ variance explained by a given effect). The term 'main' refers to the effect of an independent variable (in this case, either host genotype or virus genotype) averaged across different levels of a dependent variable (viral fitness and virulence). The term 'interaction' refers to nonadditive effects that arise due to unique combinations of host and virus genotypes. For data derived from infections with unpassaged virus, only the effect of host genotype was modeled because there is only one virus genotype. Thus, there were a total of three GLM analyses performed on the unpassaged data set; one for proviral load, infectious particle counts and splenomegaly. For data derived from infection with post-passage viruses, all three effects were modeled for proviral load, infectious particle counts and splenomegaly for a total of nine GLM analyses. Table 1 summarizes the results from these 12 independent GLM analyses. Results for each of these 12 models are provided in Supplementary Materials (Supplementary Tables 6-9 ).
As host genotypes can vary considerably in their relative permissiveness to infection and susceptibility to disease, and because some virus genotypes are generally more infectious/virulent regardless of the host genotype they were exposed to, it was important to control for these confounding effects before analyzing patterns of pathogen adaptation in response to host familiarity. Here we used GLM analysis as a post hoc statistical method for controlling these confounding variables. Specifically, during analysis of pooled data across the three independent experiments, a model was constructed that included (in this order) the effects of host genotype, virus genotype and host familiarity. During the analysis, the proportion of variation in a data set explained by each variable is removed in a stepwise manner before each subsequent effect is analyzed. Therefore, before analyzing the effect of host familiarity on patterns of pathogen adaptation, the confounding effects of host genotype and virus genotype are statistically controlled. Results from these analyses are reported within the Results section of the manuscript. To graphically represent the contribution of host familiarity on patterns of pathogen adaptation minus the confounding contribution of host genotype and virus genotype, we extracted residual variation from a GLM incorporating the effects of host genotype and virus genotype, and then plotted the residuals. Residuals are unit-less values that reflect variance remaining in a data set after controlling for a confounding variable(s). Owing to an insufficient number of degrees of freedom, the effect of host familiarity for each independent experiment (that is, A/WySn, BALB/c, DBA/2J) was estimated on the basis of pairwise analysis of the same residual variation used to construct Figures 3  and 4 . These results are reported in Supplementary Tables 3 and 4 .
Data from BALB/c animals infected with unpassaged and post-passage pathogen stocks (shown in Figures 1 and 2) as well as the 'Familiar (BALB/ c)' data set depicted in Figure 3 ) are based on pooled estimates of previously reported results, and this is explicitly defined in all relevant figures and Supplementary Table captions. 3 All other BALB/c data is unique to this study (that is, BALB/c animals (n ¼ 88) infected with A/WySn and DBA/2J post-passage virus genotypes). We graphically represent pooled BALB/c estimates in Figures 1, 2 and 3 and provide their summary statistics in relevant Supplementary Tables for two reasons. First, reporting these results in the context of the new mouse genotypes (A/WySn and DBA/2J) used in this study serves to reinforce previously published findings. Second, we expanded our serial passage studies into the DBA/2J and A/ WySn mouse strains in order to directly compare the relative foldreduction in pathogen fitness in hosts with unfamiliar MHC regions only (the BALB/c MHC-congenic comparisons) versus hosts that differed across the genome (the BALB/c, A/WySn, DBA/2J comparisons). Thus, it was essential to re-establish these results, given the new comparisons. Finally, as the BALB/c-H2
d and DBA/2J d share the same H2 region, BALB/c-H2 d data was excluded from analyses unless explicitly stated otherwise.
